Clinical Trial Update: Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a combination of dostarlimab with cisplatin and etoposide plus radiotherapy in a sandwich sequence for small cell neuroendoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Neuroendocrine Carcinoma of the Cervix

Drugs mentioned

• CISPLATIN (cisplatin)
• Dostarlimab (dostarlimab)
• Etoposide (Etoposide)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Female | Phase 2 | Status: RECRUITING